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Dear Drs Eisenach, Shafer and Trame`r,
As described in a Letter to the Editor, published in
Anesthesiology, Anesthesia & Analgesia and the Euro-
pean Journal of Anaesthesiology,1–3 an analytical propo-
fol assay inaccuracy was discovered after all six initial
studies on the PK/PD and tolerability of fospropofol had
been published.4–9 This assay inaccuracy makes the
measured propofol plasma concentrations in these pre-
viously published studies unreliable.
All six affected studies were Phase I and II studies
sponsored by a pharmaceutical company (Guilford
Pharma, Baltimore, MD, USA and later MGI Pharma,
Baltimore, MD, USA) and were performed in two inde-
pendent academic-based phase I centers in Gent,
Belgium and Erlangen, Germany. Due to the stage of
the drug testing, the study drugs were made available
by the initial Sponsor. As described previously,1–3 the
Sponsor developed and validated a specific propofol
assay. Both academic centers had no influence on the
choice of methodology for sample handling and chemical
analysis. For all six studies4–9 assays were performed at an
external laboratory (MDS Pharma Services, Montreal,
Canada) as per Sponsor decision. Finally, the original
publications were co-authored by both academic and
Sponsor-based investigators.
In a Letter to the Editor1–3 the initial owner of the drug
(MGI Pharma, Baltimore, MD, USA- not affiliated the
academic centers from the original studies) declared that
additional studies were planned using an appropriate
assay to describe the pharmacokinetics and pharmacody-
namics of fospropofol in healthy volunteers and patients.
They stated their intent to publish these results shortly,
along with an estimate of the degree of error from the
previously published studies reporting results using the
old assay. In the ‘‘In Reply’’ response, you the Editors-in-right © European Society of Anaesthesiology. Un
0265-0215  2010 Copyright European Society of AnaesthesiologyChief of Anesthesiology, Anesthesia & Analgesia and
the European Journal of Anaesthesiology requested
a publication within the next 12 months validating the
new assay, analyzing the likely error and bias in each
of the six articles in question, and determining how
the error and its correction would influence the con-
clusions.
Due primarily to transfer of ownership of the drug to
another pharmaceutical company in mid 2009 (Eisai,
Woodcliff Lake, NJ, USA), the planning of studies was
delayed. As a result and although requested by the
academic investigators immediately after the publication
of the Letter to the Editor,1–3 the investigators from the
original studies were not able to reanalyze the PK/PD of
fospropofol in human volunteers within the deadline of
12 months given by the Editors-in-Chief. As such, we, the
undersigned corresponding and senior authors from
the six original papers, in the name of all co-authors,
request that the papers in question which provide flawed
PK/PD data be retracted. We regret that we are unable
to successfully resolve the problem within the given
timeframe.
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Editor,
We read with interest the article by White et al. [1] and
would suggest that many of the issues raised could be dealt
with by attending a team resource management (TRM)
course using a high-fidelity human patient simulator. As
the authors point out, in order to reduce legal liability and
improve patient safety, professional guidelines must be
adhered to. A recent study [2] has concluded that the use of
guidelines by a professional group is best understood as a
product of the group’s social norms, work practices and
organizational culture. A TRM course concentrating on
the human factors required to follow guidelines such
as communication, leadership and teamwork may be of
benefit in promoting adherence. Anaesthetists who have
trained on a high-fidelity anaesthesia simulator previously
have been shown to respond more quickly and deviate less
from accepted guidelines [3].
Procedural errors accounted for approximately a third
of worst errors made by trainees in this study. Attendance
on simulation courses provides an opportunity to practise
skills and procedures. Whether this is using a part-task
trainer, a computer-based system or an integrated simu-
lator, evidence from cognitive psychological research on
expertise has reported that to make the transition to
expert status, many hours of practice are required
[4] and that deliberate practice is better than simple
unstructured practice [5]. TRM skills that are learnt in
the context of simulated anaesthetic emergencies are
retained and are transferable across the breadth of all
clinical activities [6]. Simulation offers the trainee the
opportunity to determine their own learning objectives
by setting the agenda to concentrate on whole procedures
without having to concentrate specifically on patient care
[7] in a safe environment.
Exploration of the medicolegal aspects of a scenario could
easily be included in the postscenario feedback as this
provides the candidate with a review of their performance
with the opportunity for reflection and video playback.
After reading their article, we aim to incorporate train-
ing on medicolegal matters into our future courses and
highlight the medicolegal aspects in the postscenario
debriefing. In conclusion, we suggest that the practice
of crisis scenarios in a high-fidelity simulation setting
provides an opportunity to reduce error, improve patient
safety and decrease the risk of litigation for anaesthetists.ight © European Society of Anaesthesiology. Una
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Editor,
Intraoperative transoesophageal echocardiography
(TEE) is a useful tool not only for monitoring surgical
patients but also for evaluating and diagnosing cardiac
lesions during surgery and guiding surgical approaches.
Several reports have described the incidental identifi-
cation of cardiac lesions using TEE.1–3 This case alerts
echocardiographers regarding the possible misinterpreta-
tion of an apparent movable cardiac mass.
A 76-year-old man was scheduled for coronary artery
bypass graft (CABG) surgery. He was admitted to our
hospital and diagnosed with acute myocardial infarction
2 months prior to the scheduled surgery. Coronary angio-
graphy revealed total occlusion in segments 1 and 6 and
significant stenosis (90%) in segment 13. The total occlu-
sion in segment 1 was alleviated by percutaneous coron-
ary intervention, resulting in nonsignificant stenosis
(25%). Preoperative transthoracic echocardiography
(TTE) revealed an ejection fraction of 67% with mild
hypokinesis of the inferior wall, trivial mitral regurgita-
tion and no abnormalities of the aortic valve. TEE was
not performed preoperatively.
After induction of anesthesia for the CABG surgery, TEE
(ACUSON-CV70, Siemens, Tokyo, Japan), which was




Midoesophageal modified long-axis view exhibited a movable mass-like
object attached to the noncoronary cusp of the aortic valve. Ao, aorta;
LA, left atrium; LV, left ventricle.Doppler, was performed. A midoesophageal, modified
long-axis view of the aortic valve revealed a
6.5 mm 3.5 mm, high-echoic, mobile, pedunculated
mass attached to the noncoronary cusp (Fig. 1 and Video
Loop 1, http://links.lww.com/EJA/A1). The movement of
the mass appeared to be synchronized with the aortic
valve. Colour flow Doppler exhibited only trivial aortic
regurgitation. The mass was visible in the wide range of
the multiplane angle from the modified long-axis view to
the true long-axis view of the aortic valve. A short-axis
view of the aortic valve revealed mild hypertrophy of the
noncoronary cusp at the level of the aortic valve (Fig. 2
and Video Loop 2, http://links.lww.com/EJA/A2). The
view was unable to provide any clear images of the arearight © European Society of Anaesthesiology. Un
Fig. 2
Midoesophageal short-axis view of the aortic valve exhibited mild
hypertrophy of the noncoronary cusp. LA, left atrium; PA, pulmonary
artery; RA, right atrium.proximal to the aortic valve due to the appearance of the
basal left ventricle, and we were unable to detect the
mass there. The movable mass was interpreted as likely
representing a tumour, thrombus, vegetation or Lambl’s
excrescences. After detailed discussion with the cardiac
surgeon regarding the movable mass and completion of
distal anastomosis of CABG, the aorta was opened and
the aortic valve was observed through the transaortic
approach. Although no abnormal structures were attached
to the aortic valve, part of the noncoronary cusp leaflet
had yellowish degenerative bulging hypertrophy. After
the aorta was closed and the cardiopulmonary bypass was
completed, the aortic valve was again evaluated by TEE.
The mass-like structure was still visible in the same view
as it was during the pre-bypass period.
Accurate diagnosis of the mass-like structure was necess-
ary in this case because a pedunculated, movable mass
carries the risk of life-threatening complications such as
stroke, embolism and acute valvular dysfunction. TEE is
a useful imaging modality for assessment of movable
intracardiac masses. With TEE, optimal high resolution
and proximity between the transducer and the heart
sometimes provide superior evaluation of the character-
istics of a movable cardiac mass compared with TTE. It
has been reported that a fibroelastoma attached to the
aortic valve was incidentally identified with intraopera-
tive TEE although it was not shown by preoperative
TTE.2,3 However, in our case, the hypertrophic region of
the aortic valve leaflet was misinterpreted as a movable
cardiac mass. It was postulated that the bulging hyper-
trophic region of the noncoronary cusp was imaged only
during diastole, this being interpreted as a movable mass
during the cardiac cycle. Misinterpretation of cardiac
lesions by TEE has been reported.4,5 A mobile mass
on a prosthetic mitral valve observed by TEE was
reportedly misinterpreted as vegetation when it was
actually a pannus.4 In our case, the hypertrophic region
of the valve appeared to be a mass-like structure that
moved with the cardiac cycle, as viewed by TEE. This is
one possible pitfall of TEE. It is extremely important,
though sometimes difficult, to differentiate mass-like
structures attached to the aortic valve. This case has
an important clinical message for the interpretation of
a movable mass on the aortic valve with TEE.
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Intraoperative awareness can traumatize those patients
who experience it and result in anxiety disorders such as
posttraumatic stress disorder.1 Although it occurs rarely,
anaesthesiologists should examine anaesthetized patients
carefully to detect its signs and try to prevent it.2–5 Most
of the common causes of intraoperative awareness are the
mechanical problems with vaporizers, anaesthetic
machines or respiratory circuits. It has been postulated
that changes in patients’ blood pressure (BP) or heart rate
caused by low concentrations of anaesthetics were con-
cealed by the use of opioids under these circumstances.6
Similar situations may occur during emergence from
anaesthesia if opioids are administered to reduce post-
operative pain. Patients’ anxiety or fear encountered
during recovery, which can be magnified by the confused
mental state, tends to be neglected. This distress, how-
ever, may be very serious and intense if patients confuse
the memories during emergence from general anaesthe-
sia with intraoperative awareness. We report two patients
who encountered severe discomfort during recovery and
asserted that they experienced intraoperative awareness.
Case reports
Case 1
A 69-year-old woman was diagnosed with stomach cancer
and admitted for a subtotal gastrectomy. She was oper-
ated on for acute appendicitis under general anaesthesia 5
years ago. She also had ulcerative colitis and took acetic
salicylic acid and prednisolone. No sedative or opioid
premedication was given before surgery. When the
patient arrived in the operating room, she was monitored
with an electrocardiogram, a noninvasive arterial BP
monitor, a pulse oximeter and a peripheral nerve stimu-
lator. Anaesthesia was induced with thiopental 250 mg
and fentanyl 100mg intravenously. After endotracheal
intubation was achieved following neuromuscular block-
ade, anaesthesia was maintained with sevoflurane and aight © European Society of Anaesthesiology. Una
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inspired/end-tidal sevoflurane and carbon dioxide were
measured with an anaesthetic machine (Primus; Drager,
Lubeck, Germany) and patient monitor (Solar 8000M;
GE Medical System, Milwaukee, Wisconsin, USA). The
sevoflurane concentration was adjusted in the range of
2.2–3.9 vol% based on the haemodynamic response of
the patient. Her vital signs were so stable during the
operation with no signs of inadequate anaesthesia, such as
hypertension, tachycardia, sweating and movement, that
no more opioids were administered. At the end of the
surgery, residual neuromuscular blockade was reversed
with neostigmine mixed with atropine, and the patient’s
lungs were ventilated with 100% oxygen. The total
anaesthesia time was 120 min. Although she did not
regain consciousness completely, we removed the endo-
tracheal tube because the patient was breathing ade-
quately and seemed very uncomfortable with it. After
observing the patient carefully for a few minutes, we
started patient-controlled analgesia [(PCA) morphine
40 mg, fentanyl 1500mg, ondansetron 4 mg, isotonic
saline 64 ml, total 100 ml, continuous infusion rate
1 ml h1, bolus 0.5 ml and lockout time 15 min] to relieve
her postoperative pain and transferred her to the post-
anaesthesia care unit (PACU). Because she had not recov-
ered consciousness after about an hour in the PACU, the
PCA was stopped, and, thereafter, she became fully awake.
After staying in the PACU for another 2 h without any
particular complaint, she was transferred to a general ward.
However, the next day, she insisted that she had experi-
enced intraoperative awareness. We visited her and asked
her about it. She told us that there were other patients
beside her, and the ceiling light was different from the one
she had seen during the induction of anaesthesia. The
place she remembered must have been the PACU, not the
operating room, so we explained that she had confused the
two places and assured her of the adequate depth of
anaesthesia during surgery. However, she disagreed with
us and asserted that she was awake during surgery. She said
that she would refuse to be operated on again under
general anaesthesia because of the horrible experience
of intraoperative awareness.
Case 2
An 81-year-old woman was admitted for a subtotal gas-
trectomy. She had undergone a repair surgery of the knee
cartilage under spinal analgesia 2 years earlier. She had a
history of hypertension and diabetes mellitus and took
amlodipine, candesartan and glimepride. Anaesthesia was
induced with thiopental 250 mg and fentanyl 100mg intra-
venously, and vecuronium 8 mg was administered. After
endotracheal intubation, anaesthesia was maintained
with desflurane, oxygen and air. The inspired and end-
tidal concentrations of oxygen, desflurane and carbon
dioxide were monitored. The desflurane concentration
was changed between 4.3 and 6.0 vol% to maintain a
sufficient depth of anaesthesia to prevent sympatheticuthorized reproduction of this article is prohibited.
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required during surgery. The total anaesthesia time was
220 min. After the operation was over, neuromuscular
blockade was reversed with neostigmine mixed with atro-
pine, and 100% oxygen was supplied. When the patient
was breathing adequately and responded to verbal com-
mands, the endotracheal tube was removed. We started
PCA (morphine 30 mg, fentanyl 1000mg, ondansetron
4 mg, isotonic saline 25 ml, total 50 ml, continuous infusion
rate 1 ml h1, bolus dose 0.5 ml and lockout time 15 min)
for the relief of pain and transferred the patient to surgical
ICU (SICU). She did not regain her consciousness com-
pletely until 3 h after her arrival at SICU and occasionally
complained of pain. After she became fully awake, she did
not mention any discomfort except postoperative pain and
was transferred to a general ward the next day. We heard
that she insisted that she had experienced intraoperative
awareness and visited her. She told us that she awoke from
anaesthesia because of pain during the operation and had
asked us to reduce her pain. She felt that she was not given
enough analgesics, although a nurse had explained to her
that more analgesics had been given. She must have
confused SICU and the operating room based on com-
munication with a nurse, and we gave her a full explanation
to clear up any misunderstandings. However, she refused
to accept our explanation and said that she would never be
operated on again under general anaesthesia for fear of
awareness during surgery.
Discussion
The subconscious recollection of intraoperative events
could be excluded based on the end-tidal inhalant level
and recall situation such as a different ceiling light and
communication with a nurse.
There was one similar case report to ours.7 A 60-year-old
woman underwent a left colectomy under general anaes-
thesia with isoflurane and N2O. After the operation was
over, she was transferred to the PACU. It was decided to
keep the endotracheal tube in place for some time
because the patient was very obese and had a history
of obstructive sleep apnoea. Morphine was administered
intermittently, and the endotracheal tube was removed
after 4 h. The next day, the patient complained of aware-
ness during the operation and refused all further oper-
ations, although the authors explained the situation.
In the course of speculation about the causes of patients’
confusion, we have found some similarities between our
cases and this one. First, opioid-containing analgesia was
started even before the patients regained consciousness
fully. Second, it took the patients a few hours to become
fully awake, and they complained of intraoperative
awareness on the first postoperative day. Finally, all
of them were probably elderly Asian women. Although
the report by Ho7 did not describe the race of the
patient, it was reported in Hong Kong, and she was
likely to be an Asian. Considering all these facts,right © European Society of Anaesthesiology. Unimmediate postoperative administration of opioids,
along with the patients’ old age and the severe pain
during a slow recovery of consciousness, could have an
influence on their confusion. It might be affected by the
racial differences because there was no report on
white patients.
Attention should be paid to discriminate between these
situations and postoperative delirium, which occurs
especially in older patients. Anticholinergic agents, such
as atropine and glycopyrrolate, are the precipitating fac-
tors for delirium after surgery. However, our patients
were alert and did not meet the criteria of postoperative
delirium, which include confusions, hallucinations and
cognitive disorders such as disorientation and memory
disorder.
Although two big awareness studies5,6 analysed multiple
aspects of awareness, they did not consider discomfort
during recovery. The anxiety and distress encountered
during recovery from anaesthesia can be confused with
intraoperative awareness and can cause patients severe
psychological stress similar to real intraoperative aware-
ness. We suggest that more attention should be paid to
postoperative alleged awareness in the elderly patients
who receive opioids during the recovery period.
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anaesthetics and contraindicates ketamine in patients
with Williams–Beuren syndrome (WBS). In our patient,
the use of sevoflurane and ketamine at analgesic doses
was unavoidable but beneficial. WBS is a rare genetical
disorder linked with an increased risk of mortality during
anaesthesia. We describe the case of a 38-year-old male
patient with WBS who underwent thoracic surgery under
general anaesthesia for pleural abrasion and pleural
talcage to treat recurring spontaneous pneumothorax.
A preoperative echocardiography revealed moderate
aortic valve stenosis. Because the mentally retarded
patient was too agitated to allow the insertion of a
peripheral venous cannula, gas induction was performed
with sevoflurane. Following, the patient was intubated
with a double lumen endotracheal tube in order to
exclude the right bronchus from ventilation. Anaesthesia
was maintained with oxygen/air/sevoflurane. In spite of a
possible link between WBS and malignant hyperther-
mia, uncertainty in the current literature does not
exclude the use of volatile agents in these patients. Also,
substances with vagolytic effects, such as ketamine
should be avoided. In our case, utilization of a small
analgesic dose of ketamine and sevoflurane was
beneficial and the patient remained haemodynamically
stable during and after the operation.
Introduction
Williams–Beuren syndrome (WBS) is a rare genetic
disorder (one birth in 20 000) characterized by facial
and severe cardiovascular malformation (supravavular
aortic stenosis and/or pulmonary artery stenosis) and
mental retardation. This is due to chromosomial micro-
deletion on 7q11.23 that involves several genes such as
the one responsible for the expression of elastine.1
Patients with this syndrome have a significant increase for
myocardial ischaemia and a higher frequency of sudden
death if under general anaesthesia or sedation.1
Case report
We describe the case of a 38-year-old man who has WBS
with moderate aortic stenosis and mental retardation. He
had no other past medical history. The patient underwent
surgery for pleural talcage under general anaesthesia for
recurring right pneumothorax.
On the day of the operation, he received a premedication
with 5 mg of midazolam and 100 mg of metoprolol orally
2 h prior to surgery. On arrival in the operating theatre,
the patient was agitated and it was impossible to insert an
intravenous line without sedation. Therefore, gas induc-
tion with 6% of sevoflurane in oxygen was performed in
order to establish an intravenous access. An ECG with a
CM5 lead configuration was applied once agitation sub-
sided during gas induction. Then, 80 mg of propofol,
20mg of sufentanyl, 25 mg of atracurium and 60 mg of
lidocaine were injected. Orotracheal intubation was per-ight © European Society of Anaesthesiology. Una
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right lung during surgery. Anaesthesia was maintained
with oxygen/air and sevoflurane with an additional bolus
of 10mg of sufentanyl. Five milligrams of ketamine was
infused during 15 min to provide postoperative analgesia.
Mean arterial blood pressure remained stable at around
70 mmHg during the whole procedure. During exclusion
of the right lung, the lowest oxygen saturation measured
was 95%. Surgery lasted for 40 min and extubation was
smooth.
One hour after the surgery, the patient was discharged
from the recovery room and transferred to the cardiothor-
acic intensive care unit where recovery was uneventful.
He was sent back to the ward the following day.
Discussion
WBS has first been described by J.C. Williams in 1961
and A.J. Beuren in 1962 in patients presenting an associ-
ation of supravalvular aortic stenosis and other symp-
toms.2,3 The facial abnormalities are characterized by
the presence of a flat nasal base, bulbous extremities,
buccodental abnormalities, a large mouth with bulging
large lower lips, a long philtrum, big cheeks, periorbital
oedema, epicanthus and sometimes stellar iris. Current
literature states that these facial abnormalities are not
linked to difficulties in airway management or oral-tra-
cheal intubation, as neither was the case in our patient.
However, other problems are frequent in adult WBS
patients: ophthalmological problems, hypothyroidism,
growth retardation, glucose intolerance and joint pro-
blems. As was the case in our patient, there is also a
characteristic neuropsychological profile with the presence
of a cognitive deficit, paradoxale use of the language
and hypersociability.
There are several reports in medical literature on sudden
death in WBS patients who underwent general anaes-
thesia or sedation. Cardiac arrest of ischaemic origin was
often preceded by arterial hypotension combined with
bradycardia. One series of autopsies revealed that 14 out
of 15 WBS patients had abnormal coronary arteries.1
Often, this was associated with supravalvular aortic
stenosis and pulmonary artery stenosis. Apart from mode-
rate aortic stenosis, no other cardiac malformations were
present in our patient.
Preoperative check-up of the WBS patient should include
an electrocardiogram and echocardiography to evaluate
the presence of aortic stenosis. Coronarography can be
requested if major haemodynamic variations are expected
during surgery. On the contrary, coronarography in a WBS
patient with mental retardation might necessitate sedation
and therefore benefit should outweigh risk.
One case report of a patient who presented masseter
spasm under general anaesthesia had raised the suspicion
that WBS is associated with malignant hyperthermia.4
Indeed, the association between WBS and malignantuthorized reproduction of this article is prohibited.
Copy
Correspondence 401hyperthermia seems plausible because of the proximity
of the chromosomial deletion responsible for WBS and
the gene CACNL2A coding for a voltage-dependent
calcium channel with mutants that are involved in malig-
nant hyperthermia. Meanwhile, a recent case report5 has
described a suspected link between postoperative malig-
nant hyperthermia and WBS. On the contrary, a study by
Mammi et al.6 has shown that the locus of CACNL2A
is outside the deleted zone of chromosome 7 in WBS.
Currently, literature does not provide a clear response
about the use of volatiles for general anaesthesia in WBS
patients. Several authors reported no complications after
use of volatiles in these patients.7 Therefore, in this
context and because of the agitation, a volatile gas induc-
tion was justified in our patient. The advantages of
ischaemic preconditioning (IPC) with volatile agents
for coronary patients are well accepted. Cardiac protec-
tion by IPC against the consequences of ischaemic
reperfusion such as myocardial ischaemia, postoperative
myocardial dysfunction and arrhythmia could be
beneficial for the WBS patient with coronary abnormal-
ities who are not always having a full cardiac preoperative
check-up. Our patient had a normal sinus rhythm and did
not have any signs of intraoperative and postoperative
myocardial ischaemia. In case of the event of intraopera-
tive supraventricular tachycardia, cardioversion should be
the preferred treatment option. Vagolytics such as keta-
mine should be avoided. Nevertheless, it is also import-
ant to treat acute postoperative pain, which is a potential
source of tachycardia. Therefore, we used ketamine in
our patient at an analgesic dose of 0.1 mg/kg, which does
not have any vagolytic effects at this dosage. This also
allows decreasing the incidence of postoperative compli-
cations in thoracic surgery that are indirectly caused by
pain such as hypoxia and pneumonia.
As WBS patient have ventricular hypertrophy and do not
tolerate a rapid rise in intraventricular volume, it is also
important to pay attention to the left ventricular pre-
charge in order to avoid sudden death. Consequently,
fluids were administered slowly and limited to 500 ml of
normotonic Ringer solution perioperatively.right © European Society of Anaesthesiology. UnConclusion
In spite of a possible link between WBS and malignant
hyperthermia, literature does currently not provide a
clear response about the use of volatiles for general
anaesthesia in WBS patients. As several authors reported
no complications after the use of volatiles in these
patients and because the mentally retarded patient was
too agitated to allow the insertion of a peripheral venous
cannula, a volatile gas induction and maintenance with
oxygen/air/sevoflurane was justified. It is also advised
in WBS patients that substances with vagolytic effects,
such as ketamine should be avoided. However, we used
ketamine at an analgesic dose of 0.1 mg/kg, which does
not have any vagolytic effects and achieved good post-
operative analgesia without any haemodynamic abnorm-
alities.Acknowledgement
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